From Dr. Google to Dr. Claude: Why the Most Important Patient Support Innovation Is Still Human Connection

Every pharmaceutical company running a patient support program is under the same pressure right now: scale. Replace calls with texts. Replace humans with AI agents. Automate touchpoints, optimize workflows, surface insights faster, do more with less.

I get the instinct. Scale is the obvious move, and AI is very good at answering basic questions in an instant—so good, in fact, that it’s already replaced something else patients used to rely on.

The healthcare industry used to worry a lot about Dr. Google. Patients would type their symptoms into a search bar and end up convinced they were going to die. Then, clinicians would spend the first five minutes of an appointment walking back whatever the internet had “diagnosed.”

Now something more capable has taken its place. Dr. Claude doesn’t just return links. It listens, it synthesizes, and it answers in plain language, and all without judgment. For millions of people facing a new diagnosis or trying to make sense of a medication they just started, AI has become the first voice they turn to. In some cases, it’s the only one. A KFF poll from earlier this year found that nearly a third of U.S. adults have already turned to AI for health information and advice.

AI is available at 2:00 a.m. It doesn’t make you feel like a burden, speaks plain English, and doesn’t rush you. For a patient who recently picked up a prescription, that accessibility matters.

But here is what AI cannot do and what our industry seems increasingly comfortable pretending it can: AI cannot make a scared patient feel less alone. AI can generate words that sound like empathy, but it cannot offer the understanding that a real person can.

In a national survey of more than 2,000 Americans living with chronic conditions, 52% of respondents reported issues with medication adherence as a direct result of loneliness. Even more telling, 68% said they struggle to find support in moments when a family member, friend, or healthcare provider is unavailable. That gap is where adherence quietly falls apart. It’s also exactly where our industry keeps trying to insert a chatbot instead of a real person.

Other industries have already run this experiment, and the results aren’t encouraging. Customer service made the same bet years before healthcare and pharma did: Automate the moment someone needs help, and the technology will catch up. It hasn’t. One 2026 study found74% of organizations have been forced to shut down or roll back a live AI customer communications agent, a rate that holds across every region and industry and does not improve with experience or investment.

Healthcare doesn’t get the luxury of finding this out the same way customer service did, through abandoned carts and angry social media posts. When the “channel” being automated is a person managing a chronic illness, the cost of getting it wrong isn’t churn. It’s a missed dose, a skipped refill, and a patient’s health on the line.

So what does this actually mean for pharma companies under pressure to scale? Not that AI has no place in the patient journey. It means protecting the moments AI can’t replace, starting with proactive outreach, before a patient has even thought to ask for help.

Here’s what this looks like in practice. A highly trained peer supporter, calling on behalf of the patient’s pharmacy, checks in within days of a new prescription being filled, before any problem has had the chance to surface. No app notification, no portal login. Just a phone call. One real patient story shows why that call matters.

Shortly after this patient filled their first prescription to manage type 2 diabetes, a peer supporter called to check in. For this patient, the medication itself was only part of the equation. Life on the road as a truck driver doesn’t leave much room for a predictable routine, and a new injectable treatment came with many questions.

A peer supporter walked through the basics first: what to do if a dose gets missed when the week’s schedule shifts without warning and how to safely dispose of used pens when “home” changes every night. Some truck stops have biohazard containers on-site, but for the ones that don’t, the patient learned a safe workaround using sealed laundry detergent containers.

The conversation didn’t stop there. This patient is self-pay and raised a concern that next Monday would be the last injection in their current supply. That timeline brought real worry: Would a savings card still be able to bring the cost down, and would it apply before the refill was needed? The peer support team flagged the cost concern and forwarded the relevant details so the right follow-up could happen before the gap became a problem.

Because this patient is out of town more than they’re home, the goal wasn’t just solving today’s question; it was making sure they’d have what they needed wherever the road took them next. The same peer supporter who made the first call is automatically scheduled to follow up two more times by phone, so the relationship doesn’t end after a single conversation.

It’s a reminder of something peer support programs see every day: Adherence isn’t just about understanding a medication. It’s about fear of cost, the logistics of a nontraditional life, and having someone who follows up before the gap becomes a missed dose.

We don’t need less technology in pharma or in healthcare. We need to stop asking technology to do the one thing it was never built for. The future of adherence isn’t Dr. Google or Dr. Claude. We need to point AI at the right job: equipping the person on the phone, not replacing them. AI can flag the patient about to fall through the cracks before anyone asks. It just can’t replace the human connection and emotional support needed to drive much-needed behavior change in patients.